SEC Form 4 · accession 0001203311-18-000002
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan G Drachman
Officer — CMO & EVP, R & D
Period of report
Jan 11, 2018
Accepted (ET)
Jan 16, 2018 · 8:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 11, 2018 | M | 6,260 | $12.00 | A | 157,778 | D | |
| Common StockF1 | Jan 11, 2018 | M | 13,156 | $10.61 | A | 170,934 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $12.00 | Jan 11, 2018 | M | 6,260 | D | — | Aug 27, 2020 | Common Stock | 6,260 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $10.61 | Jan 11, 2018 | M | 13,156 | D | — | May 7, 2020 | Common Stock | 13,156 | 7,000 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Shares vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14.
- F3Shares vested at a rate of 25% on 5/7/11 and monthly thereafter until all the shares were fully vested on 5/7/14.